OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Average Rating of “Moderate Buy” from Analysts

OrthoPediatrics Corp. (NASDAQ:KIDS) has received a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $24.00.

Several equities analysts have recently weighed in on the company. Stifel Nicolaus reduced their price target on OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating for the company in a report on Friday, October 10th. Piper Sandler reduced their price objective on OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Lake Street Capital cut their target price on shares of OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, October 10th. BTIG Research reaffirmed a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a report on Wednesday. Finally, Wall Street Zen lowered shares of OrthoPediatrics from a “hold” rating to a “sell” rating in a research report on Saturday, October 11th.

OrthoPediatrics Price Performance

Shares of OrthoPediatrics stock opened at $16.46 on Thursday. The company has a quick ratio of 3.43, a current ratio of 6.66 and a debt-to-equity ratio of 0.27. OrthoPediatrics has a 52 week low of $15.28 and a 52 week high of $32.00. The company has a market cap of $412.65 million, a PE ratio of -8.44 and a beta of 1.02. The business has a 50 day moving average of $18.98 and a 200 day moving average of $20.47.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Monday, January 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. OrthoPediatrics had a negative return on equity of 6.85% and a negative net margin of 20.06%.The firm had revenue of $25.08 million during the quarter. As a group, equities research analysts forecast that OrthoPediatrics will post -0.93 earnings per share for the current year.

Insider Activity at OrthoPediatrics

In other OrthoPediatrics news, CFO Fred Hite acquired 5,076 shares of the stock in a transaction on Thursday, August 21st. The stock was acquired at an average price of $19.41 per share, for a total transaction of $98,525.16. Following the completion of the transaction, the chief financial officer directly owned 213,065 shares of the company’s stock, valued at $4,135,591.65. This trade represents a 2.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 32.70% of the company’s stock.

Institutional Trading of OrthoPediatrics

A number of institutional investors have recently bought and sold shares of the stock. PDT Partners LLC bought a new stake in shares of OrthoPediatrics during the 1st quarter worth approximately $244,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock valued at $246,000 after purchasing an additional 645 shares in the last quarter. Los Angeles Capital Management LLC bought a new position in OrthoPediatrics in the second quarter worth approximately $220,000. R Squared Ltd bought a new position in shares of OrthoPediatrics in the 2nd quarter worth $272,000. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in shares of OrthoPediatrics by 46.8% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,148 shares of the company’s stock worth $348,000 after acquiring an additional 4,508 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.